Although impressive third quarter corporate earnings reports, declining unemployment claims, have pushed the stock market higher in recent months, concerns over a possible market correction are being raised by the continued spread of COVID-19 Delta, supply chain problems, rising inflation, and the continual spread of the COVID-19 Delta variant. We believe that Alphabet (NASDAQ) is a fundamentally sound mega-cap stock. Pfizer Inc. Abbott Laboratories Accenture plc (NYSE 🙂 and (NYSE 🙂 may be able to help avoid short-term market volatility and provide solid long-term returns. Let’s discuss.Solid third-quarter earnings reported by mega-cap companies have driven the major benchmark indexes to fresh highs lately. On October 26, the Dow Jones made a third consecutive day of gains to reach a new record high. Also that day, the S&P 500 hit a fresh high. Roughly 38% of the S&P 500 members have so far reported third-quarter earnings. The consensus earnings estimates of 83% and revenue estimates by 79% respectively have been exceeded at these companies.

Markets are rising due to strong earnings reports, declining claims, and a falling number of jobless, but factors such as an increase in COVID-19, intensifying supply chain problems, and increased inflation may soon cause a correction. It is possible to buy and keep the market higher now, according to our opinion.

With a wide market reach, expanding customer base, and impressive day-to-date developments, mega-cap stocks—which possess a market capitalization of more than $200 billion—have the potential to dodge the short-term fluctuations and deliver substantial returns in the long run. Alphabet Inc., Pfizer Inc., Abbott Laboratories, Accenture plc, (ACN), are all strong players within their industries and have sound fundamentals.

Continue reading on StockNews